TY  - GEN
AU  - Liu,Yao-Chung
AU  - Gau,Jyh-Pyng
AU  - Yu,Yuan-Bin
AU  - Hong,Ying-Chung
AU  - Yen,Chueh-Chuan
AU  - Liu,Chun-Yu
AU  - Chao,Ta-Chung
AU  - Hsiao,Liang-Tsai
AU  - Liu,Jin-Hwang
AU  - Chiou,Tzeon-Jye
AU  - Tzeng,Cheng-Hwai
TI  - Prognostic factors and treatment efficacy in patients with primary diffuse large B-cell lymphoma of the bone: single institute experience over 11 years
SN  - 1349-7235
PY  - 2014///0912
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Bone Neoplasms
KW  - drug therapy
KW  - Combined Modality Therapy
KW  - Cyclophosphamide
KW  - Disease-Free Survival
KW  - Doxorubicin
KW  - Female
KW  - Follow-Up Studies
KW  - Hospitals, General
KW  - statistics & numerical data
KW  - Hospitals, Veterans
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - Magnetic Resonance Imaging
KW  - Male
KW  - Middle Aged
KW  - Positron-Emission Tomography
KW  - Prednisone
KW  - Prognosis
KW  - Radiotherapy, Adjuvant
KW  - Remission Induction
KW  - Retrospective Studies
KW  - Rituximab
KW  - Taiwan
KW  - epidemiology
KW  - Treatment Outcome
KW  - Vincristine
KW  - Young Adult
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.2169/internalmedicine.53.0967
ER  -